Adamczyk M, Fishpaugh J R, Harrington C A, Orsulak P, Akers L
Abbott Laboratories, Abbott Park, Illinois 60064.
Ther Drug Monit. 1994 Dec;16(6):577-87. doi: 10.1097/00007691-199412000-00008.
Two methods for the quantitative determination of imipramine (IMI) and desipramine (DMI) by fluorescence polarization immunoassay (FPIA) are described. One immunoassay allows for the accurate quantification of imipramine in the presence of desipramine, while the other allows for the accurate quantification of desipramine in the presence of imipramine.
描述了两种通过荧光偏振免疫分析法(FPIA)定量测定丙咪嗪(IMI)和地昔帕明(DMI)的方法。一种免疫分析法可在存在地昔帕明的情况下准确定量丙咪嗪,而另一种则可在存在丙咪嗪的情况下准确定量地昔帕明。